Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prednisone with early ART in HIV-TB
PACTR201304000511413Unknown
- Sponsor
- University of Cape Town
- Start
- Jul 2013
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Trial of prednisone in human immunodeficiency virus infection (HIV) and Tuberculosis (TB) (2 arms), sponsored by University of Cape Town. Primary endpoint: Development of paradoxical TB-IRIS within 12 weeks of starting ART. Status: unknown.
02
Drugs
prednisone
03
Conditions
human immunodeficiency virus infection (HIV)Tuberculosis (TB)
Beyond the preview
Go deeper on PACTR201304000511413.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR201304000511413.